The Sony CRE-E10 is a mid-priced OTC hearing aid that achieved the highest SoundScore in our lab testing, earning an A grade and ranking #1 among 56 OTC devices evaluated by HearAdvisor. At $998, it represents Sony's entry into the hearing aid market with technology adapted from their acclaimed audio expertise.
In our testing, the CRE-E10 demonstrated exceptional speech performance, scoring 1.88 points above the category average for speech in quiet and an impressive 3.30 points above average for speech in noise—the latter being a critical differentiator for real-world listening situations. Music streaming quality also measured above average, reflecting Sony's audio heritage. These strengths earned the device HearAdvisor's Expert's Choice Award in 2023, 2024, and 2025.
The CRE-E10 does have measurable weaknesses. Own-voice comfort scored below the category average, and feedback handling measured 1.10 points below average—both consequences of the closed sleeve coupling required to achieve its strong speech audibility. Users sensitive to the sound of their own voice may find this trade-off less acceptable.
This device is best suited for consumers who prioritize speech clarity, particularly in noisy environments, and who value reliable streaming from iPhone devices. The visible-in-ear style with rechargeable batteries offers convenience, though the closed coupling design means it may not be ideal for those with significant own-voice sensitivity. Among mid-priced OTC options, the CRE-E10 leads in overall sound performance, outscoring competitors like the Elehear Beyond Pro (4.78) and Lexie B2 Plus (4.60).
